SonaCare Medical Receives FDA Marketing Clearance for Revised Prostate Tissue Removal Device

January 11, 2017

The FDA has granted SonaCare Medical marketing clearance for its latest version of Sonablate, a device designed for the surgical removal of prostate tissue.

This updated version of the Sonablate includes tissue monitoring using radio frequency signals to quantify changes in tissue composition and reduces overall procedure time by 40 percent. — Cynthia Jessup

View today's stories